Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis.

Windschall D, Hinze T, Hardt S, Aydin D, Gohar F

DOI: 10.1093/rap/rkag017
Published: 2026
Container: Rheumatology advances in practice
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/rap/rkag017,
  title = {Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis.},
  author = {Windschall D and Hinze T and Hardt S and Aydin D and Gohar F},
  year = {2026},
  journal = {Rheumatology advances in practice},
  doi = {10.1093/rap/rkag017},
  url = {https://doi.org/10.1093/rap/rkag017}
}

RIS

TY  - JOUR
TI  - Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis.
AU  - Windschall D
AU  - Hinze T
AU  - Hardt S
AU  - Aydin D
AU  - Gohar F
PY  - 2026
JO  - Rheumatology advances in practice
DO  - 10.1093/rap/rkag017
UR  - https://doi.org/10.1093/rap/rkag017
ER  -

APA

D, W., T, H., S, H., D, A., & F, G. (2026). Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis.. Rheumatology advances in practice. https://doi.org/10.1093/rap/rkag017

Source records

pubmed · retrieved 2026-09-25T08:26:22.881Z
europe-pmc · retrieved 2026-09-25T08:26:22.888Z